Thieme E-Books & E-Journals -
Back
CC BY 4.0 · TH Open 2019; 03(03): e259-e262
DOI: 10.1055/s-0039-1695710
Letter to the Editor
Georg Thieme Verlag KG Stuttgart · New York

Effects of the PAR-1 Antagonist Vorapaxar on Platelet Activation and Coagulation Biomarkers in Patients with Stable Coronary Artery Disease

Renske H. Olie
1   Laboratory for Clinical Thrombosis and Hemostasis, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands
2   Thrombosis Expertise Center, Maastricht University Medical Center+ (MUMC+ ), Maastricht, The Netherlands
,
Paola E. J. van der Meijden
1   Laboratory for Clinical Thrombosis and Hemostasis, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands
2   Thrombosis Expertise Center, Maastricht University Medical Center+ (MUMC+ ), Maastricht, The Netherlands
,
Henri M. H. Spronk
1   Laboratory for Clinical Thrombosis and Hemostasis, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands
,
Rene van Oerle
1   Laboratory for Clinical Thrombosis and Hemostasis, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands
,
Stale Barvik
3   Department of Cardiology, Stavanger University Hospital, Stavanger, Norway
,
Vernon V. S. Bonarjee
3   Department of Cardiology, Stavanger University Hospital, Stavanger, Norway
,
Hugo ten Cate
1   Laboratory for Clinical Thrombosis and Hemostasis, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands
2   Thrombosis Expertise Center, Maastricht University Medical Center+ (MUMC+ ), Maastricht, The Netherlands
,
Dennis W. T. Nilsen
3   Department of Cardiology, Stavanger University Hospital, Stavanger, Norway
› Author Affiliations